![Jesper Høiland](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jesper Høiland
Président chez
SCIBASE HOLDING AB (PUBL)
Fortune : 26 250 $ au 30/09/2026
Profil
Mr. Jesper Høiland is a Head-Strategy at Rani Therapeutics Holdings, Inc., an Independent Director at Allarity Therapeutics, Inc., a Chairman at SciBase Holding AB, an Independent Director at ALK-Abello A/S and a Chairman at Allarity Acquisition Corp.
He is on the Board of Directors at Allarity Therapeutics, Inc., ALK-Abello A/S and Flen Health SA. Mr. Høiland was previously employed as a Global Chief Commercial Officer & Senior VP by Ascendis Pharma A/S, an Independent Director by Concert Pharmaceuticals, Inc., a President, Chief Executive Officer& Director by Radius Health, Inc., a President & Executive Vice President by Novo Nordisk North America, Inc., a Senior Vice President-International Operations by Novo Nordisk A/S, a President & Executive Vice President by Novo Nordisk, Inc., a Management Consultant by Liseberg AB, and a General Manager by Novo Nordisk Pharmaceuticals Pty Ltd. He also served on the board at LEO Pharma A/S and Pharmaceutical Research & Manufacturers of America.
He received his undergraduate degree from Copenhagen Business School and a graduate degree from Copenhagen Business School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 07/01/2026 | 25 000 ( 0,16% ) | 26 250 $ | 30/09/2026 |
Postes actifs de Jesper Høiland
| Sociétés | Poste | Début |
|---|---|---|
| ALK-ABELLÓ A/S | Directeur/Membre du Conseil | 01/01/2023 |
| SCIBASE HOLDING AB (PUBL) | Président | 13/06/2024 |
| ALLARITY THERAPEUTICS, INC. | Directeur/Membre du Conseil | 30/06/2025 |
| RANI THERAPEUTICS HOLDINGS, INC. | Corporate Officer/Principal | 25/03/2026 |
Flen Health SA
 Flen Health SA Pharmaceuticals: MajorHealth Technology Manufactures wound and skin healing products | Directeur/Membre du Conseil | - |
Anciens postes connus de Jesper Høiland
| Sociétés | Poste | Fin |
|---|---|---|
| ASCENDIS PHARMA A/S | Corporate Officer/Principal | 23/05/2022 |
| RADIUS HEALTH, INC. | Directeur Général | 28/04/2020 |
Novo Nordisk, Inc.
 Novo Nordisk, Inc. BiotechnologyHealth Technology Develops biological medicines | President | 01/03/2017 |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Directeur/Membre du Conseil | 01/01/2016 |
| ░░░░ ░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Jesper Høiland
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
79
Relations au 1er degré
16
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 16 |
|---|---|
Novo Nordisk A/S
 Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care | Health Technology |
Radius Health, Inc.
 Radius Health, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops and commercializes bone health and related therapeutics | Health Technology |
Concert Pharmaceuticals, Inc.
 Concert Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel medicines | Health Technology |
ALK-Abello A/S
 ALK-Abello A/S Pharmaceuticals: MajorHealth Technology Develops and produces, markets products for diagnosing, treating allergies, allergic asthma & acute anaphylactic reactions | Health Technology |
Copenhagen Business School
 Copenhagen Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
LEO Pharma A/S
 LEO Pharma A/S Medical/Nursing ServicesHealth Services Provides dermatology services | Health Services |
SciBase Holding AB
 SciBase Holding AB Medical SpecialtiesHealth Technology Develops point of care device for the detection of malignant melanoma | Health Technology |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Health Technology |
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Develops biological medicines | Health Technology |
Ascendis Pharma A/S
 Ascendis Pharma A/S Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes therapies for metabolic, cardiovascular and ophthalmology | Health Technology |
Novo Nordisk North America, Inc. | |
Liseberg AB | |
Novo Nordisk Pharmaceuticals Pty Ltd.
 Novo Nordisk Pharmaceuticals Pty Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for diabetes care | Health Technology |
Allarity Therapeutics, Inc.
 Allarity Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology therapeutics | Health Technology |
Rani Therapeutics Holdings, Inc.
 Rani Therapeutics Holdings, Inc. BiotechnologyHealth Technology Engages in research and development of orally administered biological products | Health Technology |
Flen Health SA
Flen Health SA Pharmaceuticals: MajorHealth Technology Manufactures wound and skin healing products | Health Technology |
